2021 Annual Meeting | C76 - Actualización en la Neuro-inmunología de Cáncer (Neuroimmunology of Cancer Update)

Date Tuesday 04/20/21

Time 06:00 PM - 07:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Yazmin Odia, MD, MS, FAAN

Topic(s) Neuro-oncology

Learning Objectives

Los objetivos de esta conferencia incluye mejor entendimiento de
1. Actualización en la Neuro-inmunología de Cáncer
2. Síndromes Paraneoplasticos
3. Complicaciones de Inmunoterapia Oncológica

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Spanish Language

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
06:00 PM - 06:05 PM EDT	Introduction	Introduction Yazmin Odia, MD, MS, FAAN
06:05 PM - 06:25 PM EDT	Speaker	Síndromes Paraneoplasticos (Paraneoplastic Syndromes) Carlos A. Pardo-Villamizar, MD
06:25 PM - 06:45 PM EDT	Speaker	Complicaciones de Inmunoterapia Oncológica (Complications of Cancer Immunotherapy) Jose R. McFaline-Figueroa, MD, PhD
06:45 PM - 07:00 PM EDT	Q&A	Live Q&A Yazmin Odia, MD, MS, FAAN, Carlos A. Pardo-Villamizar, MD, Jose R. McFaline-Figueroa, MD, PhD

Faculty Disclosures
Yazmin Odia, MD, MS, FAAN	Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Jose R. McFaline-Figueroa, MD, PhD	Dr. McFaline-Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. McFaline-Figueroa has received research support from National Brain Tumor Society. The institution of Dr. McFaline-Figueroa has received research support from National Institutes of Health. The institution of Dr. McFaline-Figueroa has received research support from Robert Wood Johnson Foundation.